MRVI Stock: Price, Earnings History and SEC Filings
Maravai LifeSciences Holdings, Inc. (MRVI) last traded at $7.81, down 7.68% on the latest session and up 2.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.07 against an analyst estimate of $-0.07, a beat of 0.0%.
$7.81 -7.68%
1 month+1.96%
52-week high$9.42
52-week low$2.55
Volume1.70M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MRVI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.07 | $-0.07 | +0.00% |
| Mar 2026 | May 7, 2026 | $-0.03 | $-0.07 | +57.14% |
| Dec 2025 | Feb 25, 2026 | $-0.07 | $-0.09 | +22.22% |
| Sep 2025 | Nov 6, 2025 | $-0.14 | $-0.08 | -75.00% |
MRVI beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for MRVI
SEC filing data is not available right now. You can search for MRVI on SEC EDGAR.
MRVI news
- Maravai LifeSciences Announces November 2026 Investor Conference ScheduleOct 29, 2026 · finance.yahoo.com
- Is Maravai LifeSciences Holdings (MRVI) Priced Too Highly For Its Sales?Oct 27, 2026 · finance.yahoo.com
About Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. (MRVI) is a US-listed public company on Nasdaq.